Alternate costimulatory molecules in T cell activation: Differential mechanisms for directing the immune response

Histology and Histopathology

Volumn 18, Issue 4, 2003, Pages 1195-1204

  Kohlmeier, J E ^a   Benedict, Stephen H ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Activation; Costimulation; Effector; Memory; T cells

Indexed keywords

BETA1 INTEGRIN; CASPASE; CD134 ANTIGEN; CD137 ANTIGEN; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INDUCIBLE COSTIMULATOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LECTIN; LIGHT ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; OX40 LIGAND; PROGRAM DEATH 1; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; MOLECULE; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD28; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; RECEPTORS, TUMOR NECROSIS FACTOR; STIMULATION, CHEMICAL; T-LYMPHOCYTES;

EID: 0142063050     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H. and Honjo T. (1996). Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765-772.
2. Arosa F.A. (2002). CD8+CD28- T cells: Certainties and uncertainties for a prevalent human T-cell subset. Immunol. Cell Biol. 80, 1-13.
3. CBL and LAT phosphorylation. J. Immunol. 164, 6091-6095.
4. Aversa G., Chang C.C., Carballido J.M., Cocks B.G. and De Vries J.E. (1997). Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol. 158, 4036-4044.
5. Azuma M., Phillips J.H., and Lanier L.L. (1993). CD28- lymphocytes: Antigenic and functional properties. J. Immunol. 150, 1147-1159.
6. Baron V., Bouneaud C., Cumano A., Lim A., Arstila T., Kourilsky P., Ferradini L. and Pannetier C. (2003). The repertoires of circulating human CD8+ central and effector memory T cell subsets are largely distinct. Immunity 18, 193-204.
7. Bennett F., Luxenberg D., Ling V., Wang I.-M., Marquette K., Lowe D., Khan N., Veldman G., Jacobs K.A. and Valge-Archer V.E. (2003). Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 170, 711-718.
8. Bertram E.M., Tafuri A., Shahinian A., Chan V.S.F., Hunziker L., Recher M., Ohashi P.S., Mak T.W., and Watts T.H. (2002). Role of ICOS versus CD28 in antiviral immunity. Eur. J. Immunol. 32, 3376-3385.
9. Bierer B.E., Peterson A., Gorga J.C., Herrmann S.H. and Burakoff S.J. (1988). Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J. Exp. Med. 168, 1145-1156.
10. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T. and Thompson C.B. (1995). CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3, 87-98.
11. Bonecchi R., Bianchi G., Bordignin P.P., D'Ambrosio D., Lang R., Borsatti A., Sozanni S., Allavena P., Gray P.A., Mantovani A. and Sinigaglia F. (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187, 129-134.
12. Boucher L.-M., Wiegmann K., Futterer A., Pfeffer K., Machleidt T., Schutze S., Mak T.W. and Kronke M. (1995). CD28 signals through acidic sphingomyelinase. J. Exp. Med. 181, 2059-2068.
13. Carreno B.M., Bennett F., Chau T.A., Ling V., Luxenberg D., Jussif J., Baroja M.L. and Madrenas J. (2000). CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165, 1352-1356.
14. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., Collins M., Honjo T., Freeman G.J. and Carenno B.M. (2002) PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2. Eur. J. Immunol. 32, 634-643.
15. Chambers C.A. and Allison J.P. (1999). Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 11, 201-210.
16. Chambers C.A., Kuhns M.S., Egen J.G. and Allison J.P. (2001). CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19, 565-594.
17. Chen A.I., McAdam A.J., Buhlmann J.E., Scott S., Lupher M.L., Greenfield E.A., Baum P.R., Fanslow W.C., Calderhead D.M., Freeman G.J. and Sharpe A.H. (1999). Ox-40 ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 11, 689-698.
18. Chirathworn C., Tibbetts S.A., Chan M.A. and Benedict S.H. (1995). Cutting Edge: Cross-linking of ICAM-1 on T cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J. Immunol. 155, 5479-5482.
19. Chirathaworn C., Kohlmeier J.E., Tibbetts S.A., Rumsey L.M., Chan M.A. and Benedict S.H. (2002). Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation. J. Immunol. 168, 5530-5537.
20. Colantonio L., Recalde H., Sinigaglia F. and D'Ambrosio D. (2002). Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naïve T cells into Th1 or Th2 cells. Eur. J. Immunol. 32, 1264-1273.
21. Davis L.S., Oppenheimer-Marks N., Bednarczyk J.L., McIntyre B.W., and Lipsky P.E. (1990). Fibronectin promotes proliferation of naïve and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J. Immunol. 145, 785-793.
22. DeBenedette M.A., Shahinian A., Mak T.W. and Watts T.H. (1997). Costimulation of CD28- lymphocytes by 4-1BB ligand. J. Immunol. 158, 551-559.
23. DeBenedette M.A., Wen T., Bachmann M., Ohashi P., Barber B., Stocking K., Peschon J. and Watts T. (1999). Analysis of 4-1BB ligand (4-1BB-L)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163, 4833-4841.
24. Deeths M.J. and Mescher M.F. (1999). ICAM-1 and B7 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur. J. Immunol. 29, 45-53.
25. Diehl L., Den Boer A.T., Shoenberger S.P., Van Der Voort E.I., Schumacher T.N., Melief C.J., Offringa R. and Toes R.E. (1999). CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med. 5, 774-779.
26. Diehn M., Alizadeh A.A., Rando O.J., Liu C.L., Stankunas K., Botstein D., Crabtree G.R. and Brown P.O. (2002). Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA 99, 11796-11801.
27. Dong C., Juedes A.E., Temann U.A., Shresta S., Allison J.P., Ruddle N.H. and Flavell R.A. (2001). ICOS co-stimulatory receptor is essential for T cell activation and function. Nature 409, 97-101.
28. Fiorentini S., Malacarne F., Ricotta D., Licenziatti S., Solis A.A., Ausenda S., De Francesco M., Garrafa E., Simonini A., Imberti L., Balsaria A., Turano A. and Caruso A. (1999). Generation of CD28- cells from long-term-stimulated CD8+CD28+ T cells: A possible mechanism accounting for the increased number of CD8+CD28- T cells in HIV-1-infected patients. J. Leukoc. Biol. 65, 641-648.
29. Flynn S., Toellner K.M., Raykundalia C., Goodall M. and Lane P. (1998). CD4+ T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4+ T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188, 297-304.
30. Frauwirth K.A. and Thompson C.B. (2002). Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest. 109, 295-299.
31. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collings M., Wood C.R. and Honjo T. (2000). Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034.
32. Geppert T.D. and Lipsky P.E. (1988). Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants. J. Clin. Invest. 81, 1497-1505.
33. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M. and Dustin M.L. (1999). The immunological synapse: A molecular machine controlling T cell activation. Science 285, 221-227.
34. Gramaglia I., Weinberg A.D., Lemon M. and Croft M. (1998). OX40 ligand: A potent costimulatory molecule for sustaining primary CD4+ T cell responses. J. Immunol. 161, 6510-6517.
35. Gramaglia I., Jember A., Pippig S.D., Weinberg A.D., Killeen N., and Croft M. (1999). The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165, 3043-3050.
36. Hart D. and McKenzie J. (1988). Isolation and characterization of human tonsil dendritic cells. J. Exp Med. 168, 157-170.
37. Hayflick J.S., Kilgannon P. and Gallatin W.M. (1998). The intercellular adhesion molecule (ICAM) family of proteins. Immunol. Res. 17, 313-327.
38. Huet S., Groux H., Caillou B., Valentin H., Prieur A.M., and Bernard A. (1989). CD44 contributes to T cell activation. J. Immunol. 143, 798-801.
39. Hutchcroft J.E. and Bierer B.E. (1994). Activation-dependent phosphorylation of the T-lymphocyte surface receptor and associated proteins. Proc. Natl. Acad. Sci. USA 91, 3260-3264.
40. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I. and Kroczek R.A. (1999). ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 397, 263-265.
41. Jenks S.A. and Miller J. (2000). Inhibition of IL-4 responses after T cell priming in the context of LFA-1 costimulation is not reversed by restimulation in the presence of CD28 costimulation. J. Immunol. 164, 72-78.
42. Kawai K., Shahinian A., Mak T.M. and Ohashi P.S. (1996). Skin allograft rejection in CD28-deficient mice. Transplantation 61, 352-355.
43. Kohlmeier J.E., Rumsey L.M., Chan M.A. and Benedict S.H. (2003). The outcome of T cell costimulation through ICAM-1 differs from costimulation through LFA-1. Immunology 108, 152-157.
44. Kwon B.S., Tan K.B., Ni J., Oh K.O., Lee Z.H., Kim K.K., Kim Y.J., Wang S., Gentz R., Yu G.L., Harrop J., Lyn S.D., Silverman C., Porter T.G., Truneh A. and Young P.R. (1997). A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272, 14272-14276.
45. Ledbetter J.A., Martin P.J., Spooner C.E., Wofsy D., Tsu T.T., Beatty P.G. and Gladstone P. (1985). Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J. Immunol. 135, 2331-2336.
46. Lenschow D.J., Walunas T.L. and Bluestone J.A. (1996). CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
47. Lucas P.J., Negishi I., Nakayama K., Fields L.E. and Loh D.Y. (1995). Naïve CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154, 5757-5768.
48. Marlin S.D. and Springer T.A. (1987). Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 51, 813-819.
49. Marshall K.W. and Marks J.D. (2001). Engineering and characterization of a novel fusion protein incorporating B7.2 and an anti-ErbB-2 single-chain antibody fragment for the activation of Jurkat T cells. J. Immunother. 24, 27-36.
50. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., Freeman G.J. and Sharpe A.H. (2001). ICOS is critical for CD40-mediated antibody class switching. Nature 409, 102-105.
51. Melero I., Shuford W.W., Newby S.A., Aruffo A., Ledbetter J.A., Hellstrom K.E., Mittler R.S. and Chen L. (1997). Monoclonal antibodies against the 4-1BB T cell activation molecule eradicate established tumors. Nat. Med. 3, 682-685.
52. Michel J., Langstein J., Hofstadter F. and Schwarz H. (1998). A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in the sera of patients with rheumatoid arthritis. Eur. J. Immunol. 28, 290-295.
53. Monks C., Freiberg B., Kupfer H., Sciaky N. and Kupfer A. (1998). Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82-86.
54. Morishita Y., Martin P.J., Bean M.A., Yamada H. and Hansen J.A. (1986). Antigen-specific function of a CD4+ subset of human T lymphocytes with granular morphology. J. Immunol. 136, 2095-2102.
55. Ni H.-T., Deeths M.J., Li W., Mueller D.A. and Mescher M.F. (1999). Signaling pathways activated by leukocyte function-associated antigen-1-dependent costimulation. J. Immunol. 162, 5183-5189.
56. Nishimura H., Nose M., Hiai H., Minato N. and Honjo T. (1999). Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151.
57. Ozkaynak E., Wang L., Goodearl A., McDonald K., Qin S., O'Keffe T., Duong T., Smith T., Gutierrez-Ramos J.C. and Rottman J.B. (2002). Programmed death-1 targeting can promote allograft survival. J. Immunol. 169, 6546-6553.
58. Palmer E.M., Farrokh-Siar L., Van Seventer J.G. and Van Seventer G.A. (2001). IL-12 decreases activation-induced cell death in human naïve T cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function. J. Immunol. 167, 749-758.
59. Posnett D.N., Edinger J.W., Manavalan J.S., Irwin C. and Marodon G. (1999). Differentiation of human CD8 T cells. Implications for in vivo persistence of CD8+CD28- cytotoxic effector clones. Int. Immunol. 11, 229-241.
60. Raab M., Pfister S. and Rudd C.E. (2001). CD28 signaling via VAV/SLP-76 adaptors: Regulation of cytokine transcription independent of TCR ligation. Immunity 15, 921-933.
61. Ragazzo J.L., Ozaki M.E., Karlsson L., Peterson P.A. and Webb S.R. (2001). Costimulation via lymphocyte function-associated antigen-1 in the absence of CD28 ligation promotes anergy of naïve CD4+ T cells. Proc. Natl. Acad. Sci. USA 98, 241-246.
62. Riley J.L., Mao M., Kobayashi S., Biery M., Burchard J., Cavet G., Gregson B.P., June C.H. and Linsley P.S. (2002). Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99, 11790-11795.
63. Roebuck K. and Finnegan A. (1999). Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukocyte Biol. 66, 876-888.
64. Sallusto F., Lenig D., Forster R., Lipp M. and Lanzavecchia A. (1999). Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712.
65. Sallusto F. and Lansavecchia A. (2001). Exploring pathways for memory T cell generation. J. Clin Invest. 108, 805-806.
66. Salomon B. and Bluestone J.A. (1998). Cutting edge: LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J. Immunol. 161, 5138-5142.
67. Sedwick C.E., Morgan M., Jusino L., Cannon J.L., Miller J. and Burkhardt J.K. (1999). TCR, LFA-1, and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization. J. Immunol. 162, 1367-1375.
68. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., Kawai K., Ohashi P.S., Thompson C.B. and Mak T.M. (1993). Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612.
69. Shuford W.W., Klussman K., Tritchler D.D., Loo D.T., Chalupny J., Siadak A.W., Brown T.J., Emswiler J., Raecho H., Larsen C.P., Pearson C.P., Ledbetter J.A. Aruffo A. and Mittler R.S. (1997). 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186, 47-55.
70. Su B., Jacinto E., Hibi M., Kallunki T., Karin M. and Ben-Neriah Y. (1994). JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736.
71. Tafuri A., Shahinian A., Bladt F., Boucher L.M., Boucher D., Chan V.S.F., Duncan G., Odermatt B., Ho A. and Itie A. (2001). ICOS is essential for effective T-helper-cell responses. Nature 409, 105-109.
72. Tai X.G., Yashiro Y., Abe R., Toyooka K., Wood C.R., Morris J., Long A., Ono S., Kobayashi M., Hamaoka T., Neben S. and Fujiwara H. (1996). A role for CD9 molecules in T cell activation. J. Exp. Med. 184, 753-788.
73. Tan J., Whitmire J., Ahmed R., Pearson T. and Larsen C. (1999). 4-1BB ligand, a member of the TNF family is important for the generation of antiviral CD8 T cell responses J. Immunol. 163, 4859-4868.
74. Tan J., Whitmire J., Murali-Krishna K., Ahmed R., Altman J., Mittler R., Sette A., Pearson T. and Larsen C. (2000). 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J. Immunol. 164, 2320-2325.
75. Todd S.C., Lipps S.G., Crisa L., Salomon D.R. and Tsoukas C.D. (1996). CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation. J. Exp. Med. 184, 2055-2060.
76. Vallejo A.B., Brandes J.C., Weyand C.M. and Goronzy J.J. (1999). Modulation of CD28 expression: Distinct regulatory pathways during activation and replicative senescence. J. Immunol. 162, 6572-6579.
77. Van Lier R.A.W., Borst J., Vroom T.M., Klein H., Van Mourik P., Zeijlemaker W.P., and Melief C.J.M. (1987). Tissue distribution and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139, 1589-1596.
78. Van Seventer G.A., Bonvini E., Yamada H., Conti A., Stringfellow S., June C.H. and Shaw S. (1992). Costimulation of T cell receptor/CD3-mediated activation of resting human CD4+ T cells by leukocyte function-associated antigen-1 ligand intercellular adhesion molecule-1 involves prolonged inositol phospholipid hydrolysis and sustained increase of intracellular Ca2+ levels. J. Immunol. 149, 3872-3880.
79. Vinary D.S. and Kwon B.S. (1998). Role of 4-1BB in immune responses. Semin. Immunol. 10, 481-489.
80. Walunas T.L., Bakker C.Y. and Bluestone J.A. (1996). CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550.
81. Wan X., Zhang J., Luo H., Shi G., Kapnik E., Kim S., Kanakaraj P. and Wu J. (2002). A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169, 6813-6821.
82. Ward S.G., Westwick J., Hall N.D. and Sanson D.M. (1993). Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur. J. Immunol. 23, 2572-2577.
83. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., and Mark T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988.
84. Weinberg A.D., Wegmann K.W., Funatake C. and Whitham R.H. (1999). Blocking OX40/OX40 ligand interaction in vitro and in vivo leads to decreased T-cell function and amelioration of EAE. J. Immunol. 162, 1818-1826.
85. Weinberg A.D., Rivera M.M., Prell R., Morris A., Ramstad T., Vetto J.T., Urba W.J., Alvord G., Bunce C., and Shields J. (2000). Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J. Immunol. 164, 2160-2169.
86. Wherry E., Teichgraber V., Becker T., Masopust D., Kaech S., Anita R., Von Andrian U. and Ahmed R. (2003). Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunology 4, 225-234.
87. Wulfing C., Sjaastad M.D., and Davis M.M. (1998). Visualizing the dynamics of T cell activation: Intracellular adhesion molecule-1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc. Natl. Acad. Sci. USA 95, 6302-6307.
88. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T., Tafuribladt A., Brankow D., Campbell P., Chang D., Chiu L., Dai T., Duncan G. Elliot G.S., Hui A., McCabe S.M., Scully S., Shahinian A., Shaklee C.L., Van G., Mak T.M. and Senaldi G. (1999). T-cell co-stimulation through B7RP-1 and ICOS. Nature 402, 827-832.
89. Yu K.Y., Kwon B., Ni J., Zhai R., Ebner R. and Kwon B.S. (1999). A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274, 13733-13736.
90. Zheng P., Wu Y., Guo Y., Lee C. and Liu Y. (1998). B7-CTLA4 interaction enhances both production of anti-tumor cytotoxic T lymphocytes and resistance to tumor challenge. Proc. Natl. Acad. Sci. USA 95, 6284-6289.
91. Zuckerman L.A., Pullen L. and Miller J. (1998). Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation. J. Immunol. 160, 3259-3268.